Anders Tomson - 12 Jan 2023 Form 4 Insider Report for CHEMUNG FINANCIAL CORP (CHMG)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Jan 2023, 15:30:34 UTC
Prior SEC filing
13 Jan 2022
Next SEC filing
19 Jan 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Kathleen S. McKillip, Attorney-in-Fact, pursuant to Power of Attorney dated April 17, 2019.

Key filing fact

Anders Tomson filed Form 4 for CHEMUNG FINANCIAL CORP (CHMG) on 17 Jan 2023.

Key facts

  • This page summarizes Anders Tomson's Form 4 filing for CHEMUNG FINANCIAL CORP (CHMG).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Jan 2023, 15:30.

Change

  • Previous filing in this sequence was filed on 13 Jan 2022.
  • Current net transaction value: -$67,693.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CHMG transaction

COMMON STOCK

Tax liability

Transaction value
$67,693
Shares
-1,436
Change %
-4.3%
Price
$47.14
Shares after
32,291
Date
12 Jan 2023
Ownership
Direct
CHMG holding

COMMON STOCK

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
13,105
Date
12 Jan 2023
Ownership
By Qualified Plan
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes dividends issued periodically under the Issuer's Dividend Reinvestment Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .